A bacterial protein recently thought to be a unique mechanism for utilizing iron may not be after all. Researchers from the University of Georgia, the Fellowship for Interpretation of Genomes, the University of Oklahoma and the University of Utah School of Medicine report their findings in the latest issue of the online journal mBio.
The ability to acquire iron from their host is an important factor in the ability of bacteria to establish an infection. The major source of host iron in infections is heme, a component of hemoglobin and disease-causing bacteria have evolved complex mechanisms to acquire the heme and extract the iron. In the case of E. coli bacteria recent research has reported that the bacterial protein YfeX is able to remove iron from heme using a process called dechelation and leave an intact tetrapyrrole. This is totally unlike any other described biological system for iron removal from heme and, thus, would represent a dramatically new feature with potentially profound implications for understanding how bacteria cause disease.
Based on the gene sequences responsible for its production, this compound appears to be a dye-decolorizing peroxidase (DyP), a relatively recently recognized superfamily of heme-containing peroxidases that are found in fungi and bacteria.
"Given the diversity of organisms that possess DyP-type proteins, the identification of this class of proteins as heme dechelatases would have profound physiological and environmental implications. Because of this and our interest in heme metabolism, we undertook to examine in more detail the protein YfeX," write the researchers.
In the study, they propose and demonstrate that YfeX is a typical DyP with no ability to dechelate iron from heme.
"The data presented herein demonstrate that recombinant YfeX is a typical DyP-type peroxidase and does not possess the catalytic ability to dechelate iron from heme in vitro," write the researchers. "In vivo experiments with YfeX in E. coli and its homolog in Vibrio fischeri revealed no evidence that YfeX either is involved in iron acquisition from heme or generates prophyrin from exogenously supplied heme."
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.